erikkellison's profile picture. Medical Science Liaison, Cardiovascular, Bristol Myers Squibb. Content is my own.

Erik Kellison, PharmD, BCPS, BCACP, BCCP

@erikkellison

Medical Science Liaison, Cardiovascular, Bristol Myers Squibb. Content is my own.

In preparing for this talk, I was floored by all the excellent resources available to HF patients. Thank you @HFSA @American_Heart @ACCinTouch @Novartis @medlineplus @nih_nhlbi @CDCgov We can do better for our patients!

HFSA's @hfsa Storylines app may help patients self-manage #heartfailure. #HFSA2020 @erikkellison

EiranGorodeski's tweet image. HFSA's @hfsa Storylines app may help patients self-manage #heartfailure. #HFSA2020 @erikkellison


Just when you thought endothelial dysfunction was bad enough already for its involvement in a host of common, prevalent, chronic diseases, here it comes again, swinging for the bleachers.

Back to the roots: Covid is an endothelial disease; sure, the lungs are affected, but CV causes are as important for the outcome, i.e. VTE due to TF , ischemia in all organs - inflammation as the final common pathway leading to endothelial dysfunction: red it, it's worth it!

TomLuscher's tweet image. Back to the roots: Covid is an endothelial disease; sure, the lungs are affected, but CV causes are as important for the outcome, i.e. VTE due to TF , ischemia in all organs - inflammation as the final common pathway leading to endothelial dysfunction: red it, it's worth it!


I ❤️ @escardio, @drjohnm, and #FOAMed Seven Quick Thoughts on the New European AF Guidelines Teaser medscape.com/viewarticle/93… via @medscape


Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

#COVID-19 as an endothelial disease. An insightful viewpoint from Peter Libby and @TomLuscher academic.oup.com/eurheartj/arti… #cardiotwitter #CardioEd

EchoSoliman's tweet image. #COVID-19 as an endothelial disease. An insightful viewpoint from Peter Libby and @TomLuscher 

academic.oup.com/eurheartj/arti…

#cardiotwitter #CardioEd
EchoSoliman's tweet image. #COVID-19 as an endothelial disease. An insightful viewpoint from Peter Libby and @TomLuscher 

academic.oup.com/eurheartj/arti…

#cardiotwitter #CardioEd

Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

Don’t stop those ACEI and ARBS in the #COVID19 patients. Just released from the @escardio meetings. @ACCinTouch #ACCCVT @accpcardprn @JGPharmD

#ESCCongress | BRACE CORONA: heart patients hospitalised with #COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).

Cardioinfo_it's tweet image. #ESCCongress | BRACE CORONA: heart patients hospitalised with #COVID-19 can safely continue
taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).


Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress

DocDirkules's tweet image. DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress
DocDirkules's tweet image. DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress
DocDirkules's tweet image. DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress
DocDirkules's tweet image. DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress

And here I thought I’d have to wait another 8 hours for this! Just waiting on FDA now... #SGLT2i #Empagliflozin for HFrEF. CKD. ASCVD. T2DM. Jeez. Also, interesting trend for more benefit in pts on #ARNI nejm.org/doi/pdf/10.105…


Maps on w/ clinical experience

Sacubitril/valsartan superior to valsartan alone for reduction of renal events in patients with #HFpEF and #CKD, study indicates. @CardiologyToday: bit.ly/2QcxtrI



Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

Inpatient initiation of sacubitril-valsartan for patients with HFrEF may be associated with reduced hospitalizations, increased quality-adjusted life expectancy, and cost savings compared with no initiation or initiation after hospitalization ja.ma/2CkHpfg


Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC @escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed

ESC_Journals's tweet image. Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC

@escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed
ESC_Journals's tweet image. Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC

@escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed
ESC_Journals's tweet image. Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC

@escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed
ESC_Journals's tweet image. Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC

@escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed

Erik Kellison, PharmD, BCPS, BCACP, BCCP hat repostet

Diagnose of #HFpEF is challenging. H2FPEF or HFA-PEFF scores might help to identify high risks in unexplained dyspnea. Great paper @mvaduganathan et al Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community heartfailure.onlinejacc.org/content/8/8/640

EduardoPerna1's tweet image. Diagnose of #HFpEF is challenging. H2FPEF or HFA-PEFF scores might help to identify high risks in unexplained dyspnea. Great paper @mvaduganathan et al
Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community heartfailure.onlinejacc.org/content/8/8/640

Loading...

Something went wrong.


Something went wrong.